Kristan Melford

1.0k total citations
14 papers, 831 citations indexed

About

Kristan Melford is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Kristan Melford has authored 14 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cell Biology. Recurrent topics in Kristan Melford's work include Lipid metabolism and disorders (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Diabetes and associated disorders (5 papers). Kristan Melford is often cited by papers focused on Lipid metabolism and disorders (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Diabetes and associated disorders (5 papers). Kristan Melford collaborates with scholars based in United States and Germany. Kristan Melford's co-authors include André Bensadoun, Stephen G. Young, Peter Gin, Brandon S.J. Davies, Anne P. Beigneux, Michael M. Weinstein, Loren G. Fong, Rosemary L. Walzem, Mary S. Cupp and Jinny S. Wong and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Cell Metabolism.

In The Last Decade

Kristan Melford

13 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristan Melford United States	11	597	418	224	213	148	14	831
Christopher T. Johansen Canada	11	559 0.9×	358 0.9×	317 1.4×	158 0.7×	381 2.6×	19	990
Kim Nguyen Doan Germany	8	225 0.4×	299 0.7×	615 2.7×	134 0.6×	189 1.3×	11	1.0k
Laura Blinderman United States	6	144 0.2×	273 0.7×	418 1.9×	114 0.5×	250 1.7×	6	843
Reiling Peng United States	7	328 0.5×	388 0.9×	238 1.1×	37 0.2×	281 1.9×	8	696
A Sjöberg Sweden	11	157 0.3×	240 0.6×	256 1.1×	77 0.4×	159 1.1×	11	571
J Nikazy United States	9	244 0.4×	240 0.6×	181 0.8×	74 0.3×	150 1.0×	11	494
John A. Krawiec United States	9	235 0.4×	323 0.8×	469 2.1×	33 0.2×	222 1.5×	10	924
Pin Yue United States	16	291 0.5×	328 0.8×	155 0.7×	43 0.2×	265 1.8×	23	810
Victoria South United States	5	220 0.4×	290 0.7×	263 1.2×	35 0.2×	189 1.3×	8	655

Countries citing papers authored by Kristan Melford

Since Specialization

Citations

This map shows the geographic impact of Kristan Melford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristan Melford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristan Melford more than expected).

Fields of papers citing papers by Kristan Melford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristan Melford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristan Melford. The network helps show where Kristan Melford may publish in the future.

Co-authorship network of co-authors of Kristan Melford

This figure shows the co-authorship network connecting the top 25 collaborators of Kristan Melford. A scholar is included among the top collaborators of Kristan Melford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristan Melford. Kristan Melford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Beigneux, Anne P., Remco Franssen, André Bensadoun, et al.. (2009). Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase. Arteriosclerosis Thrombosis and Vascular Biology. 29(6). 956–962. 127 indexed citations

Weinstein, Michael M., Liya Yin, Anne P. Beigneux, et al.. (2008). Abnormal Patterns of Lipoprotein Lipase Release into the Plasma in GPIHBP1-deficient Mice. Journal of Biological Chemistry. 283(50). 34511–34518. 62 indexed citations

Takáhashi, Mayumí, Yaeko Hiyama, Masayoshi Yokoyama, et al.. (2008). In Vivo Arterial Lipoprotein Lipase Expression Augments Inflammatory Responses and Impairs Vascular Dilatation. Arteriosclerosis Thrombosis and Vascular Biology. 28(3). 455–462. 16 indexed citations

Beigneux, Anne P., Brandon S.J. Davies, Peter Gin, et al.. (2007). Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons. Cell Metabolism. 5(4). 279–291. 363 indexed citations

Page, Shallee T., et al.. (2006). Interaction of Lipoprotein Lipase and Receptor-associated Protein. Journal of Biological Chemistry. 281(20). 13931–13938. 14 indexed citations

Li, Huaixing, et al.. (2004). Murine glypican-4 gene structure and expression. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1679(2). 141–155. 7 indexed citations

Bensadoun, André, et al.. (2003). Purification of Rat Hepatic Lipase Essentially Free of Apolipoprotein E and Apolipoprotein B. Humana Press eBooks. 109. 151–156.

Lutz, Erlo, Yuko Kako, Hiroaki Yagyu, et al.. (2003). Mice Expressing Only Covalent Dimeric Heparin Binding-deficient Lipoprotein Lipase. Journal of Biological Chemistry. 279(1). 238–244. 4 indexed citations

Lutz, Erlo, Martin Merkel, Yuko Kako, et al.. (2001). Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues. Journal of Clinical Investigation. 107(9). 1183–1192. 49 indexed citations

10.

Sendak, Rebecca A., et al.. (2000). Binding of hepatic lipase to heparin: identification of specific heparin-binding residues in two distinct positive charge clusters. Journal of Lipid Research. 41(2). 260–268. 20 indexed citations

11.

Sendak, Rebecca A., Kristan Melford, A. S. Kao, & André Bensadoun. (1998). Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxyl-terminal heparin-binding domain. Journal of Lipid Research. 39(3). 633–646. 22 indexed citations

12.

Cisar, Laura A., Kristan Melford, Martha G. Sensel, & André Bensadoun. (1989). Heparin decreases the degradation rate of hepatic lipase in Fu5AH rat hepatoma cells. A model for hepatic lipase efflux from hepatocytes. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1004(2). 196–204. 22 indexed citations

13.

Cupp, Mary S., André Bensadoun, & Kristan Melford. (1987). Heparin decreases the degradation rate of lipoprotein lipase in adipocytes.. Journal of Biological Chemistry. 262(13). 6383–6388. 64 indexed citations

14.

Bensadoun, André, et al.. (1985). Purification and characterization of human lipoprotein lipase and hepatic triglyceride lipase. Reactivity with monoclonal antibodies to hepatic triglyceride lipase.. Journal of Biological Chemistry. 260(19). 10720–10727. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact